Hence, previous observations showing a lack of effect on RyR2 in ARVM cannot usefully inform about the action of the drug in cells from CPVT mice, where the sensitivity of RyR2 to flecainide is markedly higher. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.